Hyponatremia and extrapontine myelinolysis in a patient with COVID‐19: A case report

Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis. Until we have strong evidence to the contrary, symptomatic hypon...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical case reports Vol. 9; no. 7; pp. e04463 - n/a
Main Authors:	Abd Ur Rehman, Muhammad, Abdulrahman, Abdulrahman Fadhl, Zainab, Aariz, Paksoy, Yahya, Kharma, Nadir
Format:	Journal Article
Language:	English
Published:	England John Wiley & Sons, Inc 01-07-2021 John Wiley and Sons Inc Wiley
Subjects:	Apoptosis Brain Case Report Case Reports Coronaviruses COVID-19 Creatinine Edema Electrolytes extrapontine myelinolysis Hyponatremia Magnetic resonance imaging ODS Potassium Sodium COVID‐19 hyponatremia extrapontine myelinolysis ODS
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis. Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis.
Bibliography:	Funding information For the publication of this article Open access funding was provided by Qatar National Library
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.4463